Sufferers of Parkinson's Disease may soon have a once-a-day patch to help with the treatment of their condition. A clinical trial shows that the new "patch" is a safe and effective treatment for early Parkinson's disease.

The patch's actual name -- transdermal rotigotine -- will be sold under the brand name Neupro -- and it's already sold in Europe by manufacturer Schwarz Pharma. The patch's effectiveness -- according to the leader of the clinical trial -- is that it provides a continuous, steady delivery of an effective Parkinson's drug.